Johnson & Johnson's COVID vaccine moves into final stage of trials
Pharmaceutical giant Johnson & Johnson announced Thursday that it has fully enrolled participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate, CNN reports.
The company's Jansen unit is leading the study, which involves 45,000 participants and has been named 'Ensemble.'
According to CNN, the company believes that with the high rate of disease transmission among the general population in the United States, this number of volunteers should be enough to quickly get the data the company needs to determine if the vaccine works and to determine if it is safe.
If the study's data reveals that the drug is a viable option for Americans, the company anticipates submitting its request for emergency use authorization to the U.S. Food and Drug Administration (FDA) in February.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Parents say Baton Rouge police took 20 minutes to respond to potential...
'It's a long time coming': Iberville Parish President pleased with potential bridge...
In wake of two boating fatalities, Pointe Coupee officials hoping for safe...
Some hurricane plans to change in Tangipahoa after Ida
Location for new bridge narrowed down to three options, all in Iberville...
Southern baseball walks off Jackson State in SWAC Tournament
Southern baseball wins game one 21-2 over Alcorn
VIDEO: Former Saints and Tiger Devery Henderson talks about the difference between...
New NCAA rules tweak opens door for more SEC dominance
VIDEO: Devery Henderson Talk about Bluegrass Miracle and the Saints "Rebirth game"